Full Press Release Details
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023.
VKTX
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023
Key Takeaway: Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023
Price reaction · baseline $8.76 (2023-01-31 close) · hit after-hours · clean, no other VKTX news in the window
day 0 close
+0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss